Clinical Trial: First in Man Study of Pulsed Field Ablation System for the Treatment of Paroxysmal Atrial Fibrillation in 1 Patient

U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07452211) titled 'First in Man Study of Pulsed Field Ablation System for the Treatment of Paroxysmal Atrial Fibrillation in 1 Patient' on Feb. 28.

Brief Summary: This is the first in man study of CadioPulseTM ( pulsed field ablation system) developed and manufactured by Hangzhou Dinova EP Technology Co., Ltd, which can be used for Pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation. This study aims to initially verify the safety and efficacy of the device.

Study Start Date: Dec. 18, 2020

Study Type: INTERVENTIONAL

Condition: Paroxysmal Atrial Fibrillation (PAF)

Intervention: DEVICE: CardioPulsesTM pulsed field ablation ...